Real-world clinical effectiveness on glycaemic parameters, safety and additional benefits of Glargine U300 (Toujeo®) initiation after oral antidiabetic drug failure in insulin-naïve patients with type 2 diabetes mellitus
Background: Several studies have proved the advantages of second-generation insulin analogs in lowering intra-individual variability in plasma insulin levels, flexibility in dosing, a sustained glucose-lowering effect, and decreasing the risk of hypoglycemia. Glargine 300 is one of the newer second-...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Ráidu: | Indian Journal of Endocrinology and Metabolism |
| Fáttát: | |
| Liŋkkat: | http://www.ijem.in/article.asp?issn=2230-8210;year=2023;volume=27;issue=5;spage=426;epage=430;aulast=Shah |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|